Repaglinide 1 mg/1 (Repaglinide TABLET) 1 mg/1

Repaglinide 1 mg tablets are an oral medication used to manage blood sugar levels in adults with type 2 diabetes. This fast-acting drug helps control glucose by stimulating insulin release from the pancreas.

Strength

1 mg/1

Pack Size

1000 TABLET in 1 BOTTLE (33342-249-44)

Manufacturer / TM Owner

Macleods Pharmaceuticals Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Repaglinide is primarily used to improve glycemic control in adults with type 2 diabetes. It works by enhancing the body's natural insulin response to meals, helping to lower blood sugar levels. This medication is often prescribed as part of a comprehensive diabetes management plan, which may include diet and exercise. Repaglinide is typically taken before meals to help regulate blood sugar spikes that occur after eating.

Side Effects

Common effects of Repaglinide may include mild to moderate hypoglycemia, particularly if meals are skipped or delayed. Some users may experience gastrointestinal discomfort, such as nausea or diarrhea. It is important to monitor blood sugar levels regularly while taking this medication to ensure it is working effectively and to avoid potential low blood sugar episodes.

Precautions & Warnings

Repaglinide should be handled with care, especially for individuals with a history of hypoglycemia or liver disease. It is crucial to follow the prescribed dosage and timing to minimize the risk of side effects. Always consult a healthcare provider before starting or stopping this medication, particularly if you have other medical conditions or are taking other medications.

Avoid Interactions

Repaglinide may interact with certain medications, including other diabetes drugs, anticoagulants, and some antibiotics. Alcohol consumption should be limited, as it can increase the risk of hypoglycemia. Additionally, Repaglinide may interact with drugs that affect the liver's cytochrome P450 system, potentially altering its effectiveness or increasing the risk of side effects.

Frequently Asked Questions

Repaglinide is used to manage blood sugar levels in adults with type 2 diabetes by stimulating insulin release.

Repaglinide is typically taken orally before meals to help control blood sugar spikes after eating.

Common side effects may include hypoglycemia, nausea, and diarrhea. Regular blood sugar monitoring is recommended.

Repaglinide may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Repaglinide should be used with caution in individuals with a history of hypoglycemia or liver disease. Always consult a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.